1 |
Grimer R, Judson I, Peake D, Seddon B. Guidelines for the management of soft tissue sarcomas. Viganello-Lugano (Switzerland): European Society of Medical Oncology, National Comprehensive Cancer Network; 2010.
|
2 |
Sanfilippo R, Miceli R, Grosso F, et al. Myxofibrosarcoma: prognostic factors and survival in a series of patients treated at a single institution. Ann Surg Oncol 2011;18:720-5.
DOI
|
3 |
Burt M, Ihde JK, Hajdu SI, et al. Primary sarcomas of the mediastinum: results of therapy. J Thorac Cardiovasc Surg 1998;115:671-80.
DOI
|
4 |
Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. New York (NY): Elsevier Biomedical; 2006.
|
5 |
Huang HY, Lal P, Qin J, Brennan MF, Antonescu CR. Lowgrade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems. Hum Pathol 2004;35:612-21.
DOI
|
6 |
Luo DX, Huang MJ, Xiong B, et al. Primary mediastinal sarcoma: surgical outcomes of 21 cases. Interact Cardiovasc Thorac Surg 2013;17:982-6.
DOI
|
7 |
Mentzel T, Calonje E, Wadden C, et al. Myxofibrosarcoma: clinicopathologic analysis of 75 cases with emphasis on the low-grade variant. Am J Surg Pathol 1996;20:391-405.
|